Literature DB >> 14650232

Application of mass spectrometry to IgA nephropathy: structural and biological analyses of underglycosylated IgA1 molecules.

Yoshinari Yasuda1, Akeyo Horie, Hiroko Odani, Hitoo Iwase, Yoshiyuki Hiki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14650232     DOI： 10.1159/000074598

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  6 in total

1.  Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.

Authors:  Miho Tatematsu; Yoshinari Yasuda; Yoshiki Morita; Izumi Sakamoto; Kei Kurata; Tomohiko Naruse; Rhohei Yamamoto; Naotake Tsuboi; Waichi Sato; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2012-05-23       Impact factor: 2.801

2.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Abnormal glycosylation of serum IgG in patients with IgA nephropathy.

Authors:  Hideki Homma; Keiichi Tozawa; Takahiro Yasui; Yasunori Itoh; Yutaro Hayashi; Kenjiro Kohri
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

Review 4.  Gene expression profiling analysis in nephrology: towards molecular definition of renal disease.

Authors:  Yoshinari Yasuda; Clemens D Cohen; Anna Henger; Matthias Kretzler
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617

Review 5.  Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.

Authors:  Bruce A Julian; Stefan Wittke; Marion Haubitz; Petra Zürbig; Eric Schiffer; Brendan M McGuire; Robert J Wyatt; Jan Novak
Journal:  World J Urol       Date:  2007-07-10       Impact factor: 3.661

6.  Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.

Authors:  Zhaohui Ni; Yanhong Yuan; Qin Wang; Liou Cao; Xiajing Che; Minfang Zhang; Yuanyuan Xie; Chaojun Qi; Shan Mou
Journal:  J Transl Med       Date:  2014-07-10       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.